lead plaintiff deadline

Rosen Law Firm alerts $QURE investors with losses exceeding $100K to meet April 13 deadline in securities class action over alleged FDA approval status misrepresentation.

Rosen Law Firm urges Inovio investors with $100K+ losses to file by April 7 deadline in securities class action alleging false manufacturing and regulatory statements.

Investors in $DOOR must act by April 7, 2026 to join class action alleging material omissions regarding Owens Corning acquisition and share repurchases.

REGENXBIO faces securities class action alleging false statements about RGX-111 gene therapy. Lead plaintiff deadline April 14, 2026.

Rosen Law Firm seeks lead plaintiffs in securities lawsuit against BlackRock TCP Capital ($TCPC) alleging false investment valuations and NAV misstatements, with April 6, 2026 deadline.

Rosen Law Firm files securities lawsuit against Ultragenyx Pharmaceutical over alleged misleading claims about setrusumab's effectiveness; April 6 deadline for investors with $100K+ losses.

Rosen Law Firm urges $KD investors to join securities class action alleging false financial statements and internal control failures. April 13 deadline to serve as lead plaintiff.

Rosen Law Firm urges $VITL investors to act before May 26 deadline in securities class action alleging misleading statements about ERP system delays.

Class action lawsuit filed against $PSIX alleging false statements about data center demand and manufacturing costs. Investors have until May 19, 2026 to become lead plaintiffs.

Super Micro Computer faces securities lawsuit alleging concealed China sales violations of U.S. export controls. Investors have until May 26, 2026 to join.

Rosen Law Firm urges Apollo Global ($APO) investors to join securities lawsuit alleging executives falsely denied business dealings with Epstein. Lead plaintiff deadline: May 1, 2026.

Rosen Law Firm urges $PSFE investors with $100k+ losses to join class action alleging false statements about ecommerce exposure and merchant risks.

PomDoctor Ltd. ($POM) investors with losses exceeding $100k must act by April 7, 2026 deadline in securities fraud class action alleging false statements and manipulative trading schemes.

Securities class action filed against $ODD alleging false statements about business performance tied to advertising partner algorithm changes. Lead plaintiff deadline: May 11, 2026.

Securities lawsuit alleges REGENXBIO made misleading statements about RGX-111 gene therapy. Investors have until April 14, 2026 to file.

Rosen Law Firm urges FBRT investors to join class action alleging false dividend claims, with April 27 lead plaintiff deadline.

Rosen Law Firm files securities class action against Snowflake alleging executives concealed material information about product efficiency and pricing changes affecting consumption and revenues.

Law firm urges $DRVN investors to join class action over alleged false financial statements and unreconciled cash balances from 2023.

$EOSE faces securities class action over false capacity claims; investors must act by May 5, 2026 lead plaintiff deadline.

Class action lawsuit filed against $BSX for allegedly misleading investors about unsustainable growth in U.S. Electrophysiology segment. Lead plaintiff deadline: May 4, 2026.